Unknown

Dataset Information

0

Disease exacerbation of multiple sclerosis is characterized by loss of terminally differentiated autoregulatory CD8+ T cells.


ABSTRACT: Multiple sclerosis (MS) is an inflammatory, demyelinating disease of the central nervous system (CNS). Although its etiology remains unknown, pathogenic T cells are thought to underlie MS immune pathology. We recently showed that MS patients harbor CNS-specific CD8+ Tregs that are deficient during disease relapse. We now demonstrate that CNS-specific CD8+ Tregs were cytolytic and could eliminate pathogenic CD4+ T cells. These CD8+ Tregs were present primarily in terminally differentiated (CD27-, CD45RO-) subset and their suppression was IFN?, perforin and granzyme B-dependent. Interestingly, MS patients with acute relapse displayed a significant loss in terminally differentiated CD8+ T cells, with a concurrent loss in expression of perforin and granzyme B. Pre-treatment of exacerbation-derived CD8+ T cells with IL-12 significantly restored suppressive capability of these cells through upregulation of granzyme B. Our studies uncover immune-suppressive mechanisms of CNS-specific CD8+ Tregs, and may contribute to design of novel immune therapies for MS.

SUBMITTER: Cunnusamy K 

PROVIDER: S-EPMC4024444 | biostudies-literature | 2014 May-Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Disease exacerbation of multiple sclerosis is characterized by loss of terminally differentiated autoregulatory CD8+ T cells.

Cunnusamy Khrishen K   Baughman Ethan J EJ   Franco Jorge J   Ortega Sterling B SB   Sinha Sushmita S   Chaudhary Parul P   Greenberg Benjamin M BM   Frohman Elliot M EM   Karandikar Nitin J NJ  

Clinical immunology (Orlando, Fla.) 20140320 1-2


Multiple sclerosis (MS) is an inflammatory, demyelinating disease of the central nervous system (CNS). Although its etiology remains unknown, pathogenic T cells are thought to underlie MS immune pathology. We recently showed that MS patients harbor CNS-specific CD8+ Tregs that are deficient during disease relapse. We now demonstrate that CNS-specific CD8+ Tregs were cytolytic and could eliminate pathogenic CD4+ T cells. These CD8+ Tregs were present primarily in terminally differentiated (CD27-,  ...[more]

Similar Datasets

| S-EPMC7568335 | biostudies-literature
| S-EPMC3046327 | biostudies-literature
| S-EPMC8900158 | biostudies-literature
| S-EPMC5497536 | biostudies-literature
| S-EPMC2930011 | biostudies-other
| S-EPMC6702304 | biostudies-literature
| S-EPMC7810375 | biostudies-literature
| S-EPMC8627834 | biostudies-literature
| S-EPMC7191929 | biostudies-literature
| S-EPMC9110814 | biostudies-literature